SCHEMBL934531

SCHEMBL934531

CCC(=O)NCc1ccc(O)cc1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TRPV1 Q8NER1 2/20 0.54
CNR1 P21554 1/20 0.54
CNR2 P34972 1/20 0.54
TPSAB1 Q15661 2/20 0.50
HPGD P15428 5/20 0.49
L3MBTL1 Q9Y468 2/20 0.49
ALDH1A1 P00352 2/20 0.49
CYP3A4 P08684 1/20 0.49
CYP2C19 P33261 1/20 0.49
KDM4E B2RXH2 1/20 0.47
F13A1 P00488 1/20 0.47
MEN1 O00255 1/20 0.47
APAF1 O14727 1/20 0.47
USP2 O75604 1/20 0.47
POLB P06746 1/20 0.47
GAA P10253 1/20 0.47
MAPT P10636 1/20 0.47
ALOX15 P16050 1/20 0.47
ALOX12 P18054 1/20 0.47
MAPK1 P28482 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6388893 0.90 LTA4H (0.47) TRPV1CNR1CNR2HPGDMEN1
SCHEMBL826020 0.86 KMT2A (0.53) TPSAB1HPGDALDH1A1KDM4EKMT2A
SCHEMBL12992173 0.85 CYP3A4 (0.68) TRPV1CNR1CNR2TPSAB1HPGD
SCHEMBL660986 0.84 KMT2A (0.62) HPGDALDH1A1MEN1USP2POLB
SCHEMBL21648724 0.84 EPHX2 (0.51) TPSAB1HPGDL3MBTL1ALDH1A1CYP3A4
SCHEMBL13024401 0.84 TPSAB1 (0.50) TPSAB1HPGDALDH1A1
SCHEMBL13181415 0.84 KMT2A (0.61) TPSAB1HPGDALDH1A1POLBMAPT
SCHEMBL26847172 0.83 NPC1 (0.46) TPSAB1HPGDL3MBTL1ALDH1A1CYP3A4
SCHEMBL933833 0.82 CA12 (0.49) TPSAB1HPGDALDH1A1POLB
SCHEMBL14107294 0.82 TPSAB1 (0.48) TPSAB1HPGDL3MBTL1ALDH1A1CYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2015162216-A1 BIARYL AMIDE OR UREA DERIVATIVES AS TRPV1 LIGANDS UNIVERSITA' DEGLI STUDI DI SIENA (IT) 2015-10-29 WO claimed
WO-2022246086-A1 ANTIBODY DRUG CONJUGATES USING MATES TECHNOLOGY FOR DELIVERING CYTOTOXIC AGENTS BIOHAVEN THERAPEUTICS LTD. (US) 2022-11-24 WO disclosed
WO-2021102052-A1 DIRECTED CONJUGATION TECHNOLOGIES KLEO PHARMACEUTICALS, INC. (US) 2021-05-27 WO disclosed
EP-3394056-B1 COMPOUNDS FOR THE TREATMENT OF CANCER AND INFLAMMATORY DISEASE SHY Therapeutics LLC (US) 2021-04-14 EP disclosed
WO-2017112777-A1 COMPOUNDS FOR THE TREATMENT OF CANCER AND INFLAMMATORY DISEASE SHY Therapeutics LLC (US) 2017-06-29 WO disclosed
WO-2015162216-A1 BIARYL AMIDE OR UREA DERIVATIVES AS TRPV1 LIGANDS UNIVERSITA' DEGLI STUDI DI SIENA (IT) 2015-10-29 WO disclosed
WO-2011006935-A2 TETRAZOLE DERIVATIVES MERCK SERONO S.A. (CH) 2011-01-20 WO disclosed